Format
Sort by
Items per page

Send to

Choose Destination

Best matches for atrial fibrillation AND fibrinolytic agents AND ischemic stroke AND warfarin:

Search results

Items: 1 to 20 of 270

1.

Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).

Lip GYH, Al-Saady N, Jin J, Sun M, Melino M, Winters SM, Zamoryakhin D, Goette A.

Am J Cardiol. 2017 Sep 1;120(5):792-796. doi: 10.1016/j.amjcard.2017.06.005. Epub 2017 Jun 15.

PMID:
28709650
2.

[Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis].

Yuan C, Zhong L, Huang RC.

Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jun 24;45(6):526-535. doi: 10.3760/cma.j.issn.0253-3758.2017.06.016. Chinese.

PMID:
28648031
3.

The Efficacy and Safety of 3 Types of Interventions for Stroke Prevention in Patients With Cardiovascular and Cerebrovascular Diseases: A Network Meta-analysis.

Sun Q, Chang S, Lu S, Zhang Y, Chang Y.

Clin Ther. 2017 Jul;39(7):1291-1312.e8. doi: 10.1016/j.clinthera.2017.04.008. Epub 2017 Jun 10.

PMID:
28606562
4.

Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.

Choi HI, Ahn JM, Kang SH, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park DW, Park SJ.

JACC Cardiovasc Interv. 2017 Jun 12;10(11):1075-1085. doi: 10.1016/j.jcin.2017.02.028. Epub 2017 May 17.

PMID:
28527773
5.

Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy.

Lopes RD, Guimarães PO, Kolls BJ, Wojdyla DM, Bushnell CD, Hanna M, Easton JD, Thomas L, Wallentin L, Al-Khatib SM, Held C, Gabriel Melo de Barros E Silva P, Alexander JH, Granger CB, Diener HC.

Blood. 2017 Jun 1;129(22):2980-2987. doi: 10.1182/blood-2016-08-731638. Epub 2017 Mar 29.

PMID:
28356246
6.

Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation.

Xian Y, O'Brien EC, Liang L, Xu H, Schwamm LH, Fonarow GC, Bhatt DL, Smith EE, Olson DM, Maisch L, Hannah D, Lindholm B, Lytle BL, Pencina MJ, Hernandez AF, Peterson ED.

JAMA. 2017 Mar 14;317(10):1057-1067. doi: 10.1001/jama.2017.1371.

PMID:
28291892
7.

Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective.

Athanasakis K, Boubouchairopoulou N, Karampli E, Tarantilis F, Savvari P, Bilitou A, Kyriopoulos J.

Am J Cardiovasc Drugs. 2017 Apr;17(2):123-133. doi: 10.1007/s40256-016-0204-1.

PMID:
27882517
8.

Combined aspirin and anticoagulant therapy in patients with atrial fibrillation.

So CH, Eckman MH.

J Thromb Thrombolysis. 2017 Jan;43(1):7-17. doi: 10.1007/s11239-016-1425-5.

9.

Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.

Buck J, Kaboli P, Gage BF, Cram P, Vaughan Sarrazin MS.

Am Heart J. 2016 Sep;179:186-91. doi: 10.1016/j.ahj.2016.03.029. Epub 2016 Jun 21.

PMID:
27595695
10.

Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non-valvular atrial fibrillation.

Bertozzo G, Zoppellaro G, Granziera S, Marigo L, Rossi K, Petruzzellis F, Perissinotto E, Manzato E, Nante G, Pengo V.

J Thromb Haemost. 2016 Nov;14(11):2124-2131. doi: 10.1111/jth.13427. Epub 2016 Sep 19.

PMID:
27471198
11.

Safety and Feasibility of Treatment with Rivaroxaban for Non-Canonical Indications: A Case Series Analysis.

Acanfora D, Acanfora C, Scicchitano P, Longobardi M, Furgi G, Casucci G, Lanzillo B, Dentamaro I, Zito A, Incalzi RA, Ciccone MM.

Clin Drug Investig. 2016 Oct;36(10):857-62. doi: 10.1007/s40261-016-0436-5.

PMID:
27401780
12.

Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.

Hsu JC, Maddox TM, Kennedy K, Katz DF, Marzec LN, Lubitz SA, Gehi AK, Turakhia MP, Marcus GM.

J Am Coll Cardiol. 2016 Jun 28;67(25):2913-23. doi: 10.1016/j.jacc.2016.03.581.

13.

[Cerebral infarction and transient ischemic attack].

Sahara N, Kuwashiro T, Okada Y.

Nihon Rinsho. 2016 Apr;74(4):666-70. Review. Japanese.

PMID:
27333757
14.

Failure of old and new anticoagulants to prevent ischemic stroke in high-risk atrial fibrillation: a case report.

Bilora F, Adamo A, Pomerri F, Prandoni P.

Minerva Cardioangiol. 2016 Aug;64(4):494-6.

PMID:
27228488
15.

Clinical and economic impact of rivaroxaban on the burden of atrial fibrillation: The case study of Japan.

Hori M, Ikeda S, Okumura K, Matsuda S, Koretsune Y, Montouchet C, Watanabe-Fujinuma E, Evers T, Rossi B, Ruff L, Briere JB.

J Med Econ. 2016 Sep;19(9):889-99. doi: 10.1080/13696998.2016.1182919. Epub 2016 May 12.

PMID:
27112188
16.

Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry.

Watanabe E, Yamamoto M, Kodama I, Inoue H, Atarashi H, Okumura K, Yamashita T, Lip GY, Kodani E, Okuyama Y, Chishaki A, Kiyono K, Origasa H; J-RHYTHM Registry Investigators.

Int J Cardiol. 2016 Jun 1;212:311-7. doi: 10.1016/j.ijcard.2016.03.008. Epub 2016 Mar 19.

PMID:
27057949
17.

Factors Associated with Thrombolysis Outcome in Ischemic Stroke Patients with Atrial Fibrillation.

Zhao Q, Li X, Dong W, Ye M, Cao Y, Zhang M, Cheng Q, Zhou J, Chen G, Yu M, Hong S, Wei X, Wang B, Cui G, Zhang P, Ding H, Xu R, Chen Y, Xu Y.

Neurosci Bull. 2016 Apr;32(2):145-52. doi: 10.1007/s12264-016-0019-8. Epub 2016 Mar 7.

18.

Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.

Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Origasa H; J-RHYTHM Registry Investigators.

J Stroke Cerebrovasc Dis. 2016 Mar;25(3):585-99. doi: 10.1016/j.jstrokecerebrovasdis.2015.11.020. Epub 2015 Dec 22.

19.

ATRIAL FIBRILLATION AND STROKE PREVENTION PRACTICES IN PATIENTS WITH CANDIDACY FOR ANTICOAGULATION THERAPY.

Ullah I, Ahmad F, Ahmad S, Hayat Y.

J Ayub Med Coll Abbottabad. 2015 Jul-Sep;27(3):669-72.

PMID:
26721036
20.

Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation.

Forslund T, Wettermark B, Hjemdahl P.

Eur J Clin Pharmacol. 2016 Mar;72(3):329-38. doi: 10.1007/s00228-015-1983-z. Epub 2015 Nov 27.

PMID:
26613954

Supplemental Content

Loading ...
Support Center